<?xml version="1.0" encoding="UTF-8"?>
<ref id="bib0009">
 <element-citation publication-type="journal" id="sbref0009">
  <person-group person-group-type="author">
   <name>
    <surname>Ghosh</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Goldin</surname>
    <given-names>E.</given-names>
   </name>
   <name>
    <surname>Gordon</surname>
    <given-names>F.H.</given-names>
   </name>
   <name>
    <surname>Malchow</surname>
    <given-names>H.A.</given-names>
   </name>
   <name>
    <surname>Rask-Madsen</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Rutgeerts</surname>
    <given-names>P.</given-names>
   </name>
   <name>
    <surname>Vyhnálek</surname>
    <given-names>P.</given-names>
   </name>
   <name>
    <surname>Zádorová</surname>
    <given-names>Z.</given-names>
   </name>
   <name>
    <surname>Palmer</surname>
    <given-names>T.</given-names>
   </name>
   <name>
    <surname>Donoghue</surname>
    <given-names>S.</given-names>
   </name>
   <collab>Natalizumab Pan-European Study Group</collab>
  </person-group>
  <article-title>Natalizumab for active Crohn's disease</article-title>
  <source>N. Engl. J. Med.</source>
  <volume>348</volume>
  <year>2003</year>
  <fpage>24</fpage>
  <lpage>32</lpage>
  <pub-id pub-id-type="pmid">12510039</pub-id>
 </element-citation>
</ref>
